Clinical promise of next-generation complement therapeutics
The complement system plays a key role in pathogen immunosurveillance and tissue
homeostasis. However, subversion of its tight regulatory control can fuel a vicious cycle of …
homeostasis. However, subversion of its tight regulatory control can fuel a vicious cycle of …
The complexity and heterogeneity of monoclonal immunoglobulin–associated renal diseases
S Sethi, SV Rajkumar, VD D'Agati - Journal of the American …, 2018 - journals.lww.com
Monoclonal gammopathies are characterized by the overproduction of monoclonal Ig (MIg)
detectable in the serum or urine resulting from a clonal proliferation of plasma cells or B …
detectable in the serum or urine resulting from a clonal proliferation of plasma cells or B …
[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …
THJ Goodship, HT Cook, F Fakhouri, FC Fervenza… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G)
complement plays a primary role in disease pathogenesis. Herein we report the outcome of …
complement plays a primary role in disease pathogenesis. Herein we report the outcome of …
[HTML][HTML] Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN
S Sethi, M Haas, GS Markowitz… - Journal of the …, 2016 - journals.lww.com
Renal pathologists and nephrologists met on February 20, 2015 to establish an
etiology/pathogenesis-based system for classification and diagnosis of GN, with a major aim …
etiology/pathogenesis-based system for classification and diagnosis of GN, with a major aim …
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis
L Beck, AS Bomback, MJ Choi, LB Holzman… - American Journal of …, 2013 - Elsevier
Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to …
ages throughout the world. Because these disorders are relatively rare, it is difficult to …
Acute glomerulonephritis
S Sethi, AS De Vriese, FC Fervenza - The Lancet, 2022 - thelancet.com
Glomerulonephritis is a heterogeneous group of disorders that present with a combination of
haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree …
haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree …
C3 glomerulopathy: clinicopathologic features and predictors of outcome
NR Medjeral-Thomas… - Clinical Journal of the …, 2014 - journals.lww.com
Results Eighty patients with C3 glomerulopathy were identified: 21 with DDD and 59 with
C3GN. Patients with DDD were younger, more likely to have low serum C3 levels, and more …
C3GN. Patients with DDD were younger, more likely to have low serum C3 levels, and more …
[HTML][HTML] Bacterial infection–related glomerulonephritis in adults
SH Nasr, J Radhakrishnan, VD D'Agati - Kidney international, 2013 - Elsevier
In the past, most cases of bacterial infection–related glomerulonephritis (IRGN) occurred in
children following streptococcal upper respiratory tract or skin infections and were called …
children following streptococcal upper respiratory tract or skin infections and were called …
[HTML][HTML] C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy
AS Bomback, D Santoriello, RS Avasare… - Kidney international, 2018 - Elsevier
C3 glomerulonephritis (C3GN) and dense deposit disease comprise the two classes of C3
glomerulopathy. Studies from Europe and Asia have aided our understanding of this …
glomerulopathy. Studies from Europe and Asia have aided our understanding of this …
[HTML][HTML] Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
C Rabasco, T Cavero, E Román, J Rojas-Rivera… - Kidney international, 2015 - Elsevier
C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …
dominant deposits of C3 on immunofluorescence. To explore the effect of …